Cart is empty A team of researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS), led by Assistant Professor Anand Jeyasekharan, has discovered a unique combination of oncogenes that could predict treatment resistance, and hence unfavorable outcomes, of patients with diffuse large B cell lymphoma (DLBCL), the most common type of blood cancer in Singapore and globally.
Leave A Comment